Frozen Shakes Recalled Over Listeria Infections Kill 12
The U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration have made several public safety announcements about this outbreak since it was discovered in October 2024.
Here's a list of products included in the recall.
Frozen shakes manufactured by Prairie Farms Dairy Inc. are being recalled by the U.S. Food and Drug Administration (FDA) over listeria concerns. The outbreak has left 38 people sick, 37 hospitalized, and 12 dead, according to an updated FDA product recall alert.
The FDA says the nutritional supplement shakes are behind the recent run of infections impacting those between the ages of 43-101 the hardest. The majority of those who required hospitalization told local and state public health officials that they had either spent time in a hospital setting or were living in a long-term care facility prior to coming down with symptoms, according to a statement on the U.S. Center for Disease Control and Prevention (CDC) website.
The CDC says that the Prairie Farms drinks are served in these settings under other brand names like Sysco Imperial and Lyons ReadyCare, and that the recalled items have been shipped directly to foodservice customers and distributors, and are unlikely to be on consumer shelves. But, if you believe you have impacted product, do not consume it and throw it out immediately.
The recalled items include 4 oz. Frozen Supplemental Shakes that feature best buy dates of 02/21/25 to 02/21/2026 (although some may not feature dates at all), and the recall includes the following flavors:
Vanilla
Chocolate
Strawberry
Strawberry Banana
The FDA says cases tied to these nutritional drinks have been documented in 21 states, including Alabama, California, Texas, Pennsylvania, and Washington state. You can find a complete list of the states included in the outbreak by visiting the FDA's website.
According to the CDC, the initial outbreak likely started with illnesses investigated in 2018. The agency was unable to determine the cause of the infection at the time, and they struggled with similar outbreaks again in 2021 and 2023. Then six new listeria infections popped up at the end of 2024, which is when the agency made a breakthrough.
'CDC reopened the investigation in October 2024 after six new illnesses were reported,' the agency said in a statement on its website. 'In February 2025 after traceback identified a product of interest, the outbreak strain was found in environmental samples from Prairie Farm.'
While listeria outbreaks aren't always fatal, some people may become very ill. That's especially true for anyone with pre-existing conditions or a weakened immune system, and the elderly.
According to the FDA, listeria symptoms may include:
Nausea, vomiting, and diarrhea
Muscle aches
Fever
Fatigue
Stiff neck
Confusion
Headache
Convulsions
Loss of balance
While the products involved in this outbreak have been identified and recalled, the CDC cautions that the actual number of infections tied to this outbreak is likely higher than what is currently being reported.
Not only that, but the infections may also extend to states not included in the current alert, since some people may not be symptomatic yet, and others may not seek medical care or may not be tested for listeria by their doctor.
Consumers with additional questions about the outbreak are advised to contact the company directly by emailing frozenshakerecall@lyonsmagnus.com or visiting the company's website.
You Might Also Like
Can Apple Cider Vinegar Lead to Weight Loss?
Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
What's Behind Hologic's Positive Long-Term Outlook for Cytology Unit?
Hologic HOLX is a leading name in the cytology space, with its Cytology business, part of its Diagnostics franchise, primarily focusing on screening for cervical cancer. The company has pioneered the first FDA-approved liquid-based cytology test — the ThinPrep Pap test — and the first FDA-approved mRNA-based HPV test — the Aptima HPV Assay. Co-testing — combining a Pap test with an HPV test — is the most sensitive testing option for cervical cancer screening compared to either test used alone. While this business of Hologic has historically been a flattish to single-digit grower, the company has continued to invest in it, like the 2024 launch of the Genius digital cytology system. It was a significant introduction, marking the only FDA-cleared digital cytology system that combines deep-learning-based AI with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells. HOLX management noted that if not for the sales headwinds in China, Cytology would have grown in low single digits in the second quarter of fiscal 2025, driven by the rollout of its Genius digital diagnostics system, instead of reporting a 2.2% decline. With more labs around the world implementing this in-house innovation, Hologic has received strong positive feedback. Genius replaces the traditional manual review of path slides, which was previously conducted on glass under a microscope, by capturing a digital image of the slide, which can be reviewed remotely from anywhere in the customer's network on the company's review station. These workflow advantages not only address their growing labor shortages but also enable cervical cancer screening in regions with limited infrastructure. Because the Genius system requires an overhaul of the traditional pet screening workflow, Hologic expects the full rollout to be a multi-year process, serving as a growth driver for the next several quarters. HOLX's Peers in Cervical Cancer Screening Quest Diagnostics DGX offers a complete menu of solutions for screening and diagnosing cervical cancer. In April this year, DGX introduced a new solution aimed at expanding access to human papillomavirus (HPV) screening to help identify women who are at risk of developing cervical cancer. With this new offering, physicians can offer patients the option to collect their specimen for HPV screening in a physician's office or other healthcare setting. Quest Diagnostics' latest test uses the FDA-cleared HPV self-collection solution from Roche, approved for use with Roche Holding AG's RHHBY cobas HPV test in May 2024. Roche's cervical cancer portfolio includes three clinically validated tests to help identify women at risk and improve the detection of high-grade disease in a single round of screening. The cobas HPV test is the first clinically validated, FDA-approved, CE-IVD marked HPV DNA test for all cervical screening indications — primary screening, ASC-US triage and co-testing. The CINtec PLUS Cytology test is the only FDA-approved triage test that uses dual biomarker technology to simultaneously detect p16 and Ki-67 in women with HPV-positive results. Roche's CINtec Histology test uses advanced p16 biomarker technology to confirm cervical lesions due to transforming HPV infections. HOLX Stock Performance, Valuation and Estimates In the past six months, Hologic shares have risen 5.2% against the industry's 11.9% fall. Image Source: Zacks Investment Research Hologic is trading at a forward three-year price-to-earnings of 15.23X, lower than the industry average of 28.67X. The stock carries a Value Score of B at present. Image Source: Zacks Investment Research Consensus estimates for Hologic's fiscal 2025 earnings are showing a mixed trend. Image Source: Zacks Investment Research HOLX stock currently carries a Zacks Rank #3 (Hold).You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Roche Holding AG (RHHBY) : Free Stock Analysis Report Quest Diagnostics Incorporated (DGX) : Free Stock Analysis Report Hologic, Inc. (HOLX) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
an hour ago
- Yahoo
California resident tests positive for plague
A resident in South Lake Tahoe, California, has tested positive for plague, according to local health officials. The person is believed to have been bitten by an infected flea while camping, officials said. In a separate incident last month, a person in Arizona died from plague. Plague is a disease caused by a type of bacteria that usually results in about seven cases nationally each year, according to the Centers for Disease Control and Prevention. It occurs naturally in areas of the western U.S., where it circulates among wild rodents and other animals. Humans usually get infected through the bite of an infected rodent flea or by handling an infected animal. Symptoms, including fever, nausea, weakness and swollen lymph nodes, usually show up within two weeks of exposure, according to health officials. "Plague is naturally present in many parts of California, including higher elevation areas of El Dorado County," Kyle Fliflet, El Dorado County's acting director of public health, said in a statement. "It's important that individuals take precautions for themselves and their pets when outdoors, especially while walking, hiking and or camping in areas where wild rodents are present." The disease can be cured with antibiotics, which must be given quickly to prevent serious illness or death. At least 15 people have died from plague since 2000, the latest CDC data shows. MORE: Leading pediatrician group recommends COVID vaccine for infants, toddlers in contrast with RFK Jr. The risk to the public of exposure as well as the risk of human-to-human transmission remains low, according to health officials. Solve the daily Crossword
Boston Globe
an hour ago
- Boston Globe
Why COVID is spreading again this summer
Researchers have braced for an uptick. Though the virus is largely unpredictable — variants shape-shift and symptoms can change from one infection to the next — COVID cases have gone up every summer since the pandemic began. Around this time last year, there were higher levels of COVID in wastewater than there are currently; this appears to be, so far, a milder wave. As of June, when the CDC last updated its variant tracker, the COVID variant NB.1.8.1. — nicknamed 'Nimbus' — accounted for the most cases in the United States, around 43 percent. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up The variant does not appear to make people sicker than other recent strains of the virus, but it does have a few additional mutations that might make it more transmissible and better at evading the immune system's defenses, said Dr. Aubree Gordon, an infectious disease epidemiologist at the University of Michigan. Advertisement The latest data suggests that while we're not in a full-on surge, we are in a late summer upswing, said Dr. Ziyad Al-Aly, a senior clinical epidemiologist at Washington University in St. Louis. 'Very clearly, the numbers are going up,' he said. 'It's here.' Scientists point to a few reasons the virus reliably spreads each summer: Advertisement People spend time in air-conditioned spaces. Summer spikes may seem counterintuitive: People often spend more time outside when the weather's warm, and the virus has a much harder time circulating outdoors. But the heat also drives people inside to seek refuge in air-conditioned spaces with no windows open, leading to poor ventilation. The colder the environment, the longer the virus survives, and the easier COVID spreads, Al-Aly said. Summer travel and crowds fuel the spread. People travel more during the summer, cramming into airports and packing into trains. The Fourth of July holiday, in particular, creates a 'ripe breeding ground for COVID to run around,' said Dr. Davey Smith, an infectious disease specialist at the University of California, San Diego, similar to how infections tend to rise after Thanksgiving and Christmas. Even if people are outside at an event like a music festival, the virus can still spread in crowds. Infected people breathe out respiratory droplets and tiny particles of virus; when people wedge tightly enough together, they can inhale those contaminated droplets. Immunity to the virus can fade by summer. COVID, like many respiratory viruses, also rises in the winter. People who get COVID during the winter months will likely have good protection from reinfection for around four to six months, depending on how quickly new variants develop, Smith said. But by the time summer rolls around, immunity tends to wane, and people are susceptible to getting sick again. The same goes for people who get vaccinated in the fall or winter; their immunity dwindles, Al-Aly said, enabling a wave of new cases. Bottom line: If you feel sick, test. Advertisement COVID strikes in the summer more often than some other respiratory viruses with similar symptoms. If you're coughing and sniffling during summer, you may be more likely to have COVID than the flu or respiratory syncytial virus — and you should reach for a COVID test, Al-Aly said. The summer uptick underscores the importance of getting vaccinated, he added. But it's unclear currently how widely available updated COVID vaccines might be this year. The rising levels of COVID don't present a 'panic situation,' Al-Aly said, but people should 'be aware that numbers are now higher than they were a couple months ago.' This article originally appeared in
